ImmunoglobuliN in the Treatment of Encephalitis

The IgNiTE Study

A study testing a new treatment for children with encephalitis.

The Department of Paediatrics at the University of Oxford, in collaboration with NHS Trusts across the United Kingdom, is currently running a study for hospitalised children with encephalitis. The study will assess whether a treatment called intravenous immunoglobulin (IVIg, sometimes referred to as antibody treatment) has any benefit for these children when given early during the hospital admission.

Vaccines Against Salmonella Typhi

You are invited to take part in a study to test how different vaccines prevent infection with Salmonella Typhi.  The study is being run by the Oxford Vaccine Group, part of the University of Oxford.

If you are aged 18 to 60 years old and in good health then you may be eligible to take part in the study. We will provide reimbursement for your time and inconvenience. The total study participation time is 13 to 15 months.

Subscribe to Trials - Oxford Vaccine Group RSS